Hamel Associates, Inc. Abbott Laboratories Transaction History

Hamel Associates, Inc.

$315 Million
Q2 2024

A detailed history of Hamel Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Hamel Associates, Inc. holds 14,617 shares of ABT stock, worth $1.63 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

14,617

Previous 17,213 15.08%

Holding current value

$1.63 Million

Previous $1.96 Million 22.39%

% of portfolio

0.48%

Previous 0.63%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$100.73 - $112.44 $261,495 - $291,894	-2,596 Reduced 15.08%	14,617 $1.52 Million
Q1 2024 Apr 23, 2024	SELL	$109.52 - $120.96 $139,638 - $154,224	-1,275 Reduced 6.9%	17,213 $1.96 Million
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $119,050 - $145,728	-1,320 Reduced 6.66%	18,488 $2.03 Million
Q3 2023 Nov 03, 2023	BUY	$95.53 - $114.62 $76,424 - $91,696	800 Added 4.21%	19,808 $1.92 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $435,369 - $485,092	-4,320 Reduced 18.52%	19,008 $2.07 Million
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $1.31 Million - $1.54 Million	-13,495 Reduced 36.65%	23,328 $2.36 Million
Q4 2022 Feb 06, 2023	SELL	$95.06 - $111.52 $146,392 - $171,740	-1,540 Reduced 4.01%	36,823 $4.04 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $720,862 - $834,623	7,450 Added 24.1%	38,363 $3.71 Million
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $17,862 - $21,589	-175 Reduced 0.56%	30,913 $3.36 Million
Q1 2022 May 06, 2022	SELL	$114.02 - $139.04 $16,418 - $20,021	-144 Reduced 0.46%	31,088 $3.68 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $20,217 - $24,755	175 Added 0.56%	31,232 $4.4 Million
Q3 2021 Nov 08, 2021	SELL	$116.66 - $129.06 $293,983 - $325,231	-2,520 Reduced 7.51%	31,057 $3.67 Million
Q2 2021 Aug 04, 2021	SELL	$105.79 - $124.53 $140,171 - $165,002	-1,325 Reduced 3.8%	33,577 $3.89 Million
Q1 2021 May 04, 2021	BUY	$108.84 - $128.23 $165,981 - $195,550	1,525 Added 4.57%	34,902 $4.18 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $12,285 - $13,387	117 Added 0.35%	33,377 $3.65 Million
Q3 2020 Nov 09, 2020	BUY	$91.64 - $111.29 $61,857 - $75,120	675 Added 2.07%	33,260 $3.62 Million
Q1 2020 May 07, 2020	BUY	$62.82 - $91.86 $746,615 - $1.09 Million	11,885 Added 57.42%	32,585 $2.57 Million
Q2 2019 Aug 05, 2019	SELL	$72.88 - $85.0 $29,152 - $34,000	-400 Reduced 1.9%	20,700 $1.74 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $72,842 - $88,066	-1,100 Reduced 4.95%	21,100 $1.69 Million
Q1 2018 May 03, 2018	SELL	$56.27 - $63.62 $9,847 - $11,133	-175 Reduced 0.78%	22,200 $1.33 Million
Q2 2017 Aug 11, 2017	BUY	N/A	22,375	22,375 $1.09 Million

Others Institutions Holding ABT

# of Institutions

3,124

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $195B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamel Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hamel Associates, Inc. with notifications on news.

Account

Hamel Associates, Inc. Abbott Laboratories Transaction History